Gene therapy shows promise for treating Niemann-Pick disease type C1
Descrição
NIH researchers demonstrated that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1.
Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression
IJMS, Free Full-Text
Community News – NNPDF
mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient Fibroblasts
IJMS, Free Full-Text
Diseases, Free Full-Text
IJMS, Free Full-Text
Full article: Current advancements in therapy for Niemann-Pick disease: progress and pitfalls
Promising gene replacement therapy moves forward
PDF) Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
New gene therapy shows promise in reversing chronic pain
Niemann–Pick Disease Type C: Induced Pluripotent Stem Cell–Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy - Daozhan Yu, Manju Swaroop, Mengqiao Wang, Ulrich Baxa, Rongze Yang, Yiping Yan, Turhan
Miglustat improves swallowing in children and adolescents with Niemann-Pick type C1 disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)
